Dr. Thomas R. Murphy, MD
Allergy & Immunology (Allergy & Immunology Physician)
- Medicare participating
At a glance
- Medical school
- Loyola University of Chicago, Stritch School of Medicine (2000)
- Years since graduation
- 26
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 430
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2000Medical school: Loyola University of Chicago, Stritch School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Allergy & Immunology Physician primary
SC license 29226 -
Allergy & Immunology (Internal Medicine) Physician
MA license 215341
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Charleston Ent Associates, LLC (78 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 430
- Services billed
- 2,935
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Professional service for preparation and provision of 1 or more antigens | 985 | 56 |
| Professional service for multiple injections of allergen | 397 | 94 |
| Established patient office or other outpatient visit, 30-39 minutes | 257 | 209 |
| New patient office or other outpatient visit, 60-74 minutes | 170 | 170 |
| Professional service for single injection of allergen | 105 | 22 |
| Diagnostic exam of nasal passages using an endoscope | 104 | 103 |
| Established patient office or other outpatient visit, 20-29 minutes | 89 | 83 |
| Established patient office or other outpatient visit, 40-54 minutes | 81 | 74 |
| New patient office or other outpatient visit, 45-59 minutes | 51 | 51 |
| Test to measure the level of nitric oxide gas | 47 | 45 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Azelastine Hcl Other prescribers in Charleston, SC | 519 |
| Fluticasone Propionate Other prescribers in Charleston, SC | 325 |
| Ipratropium Bromide Other prescribers in Charleston, SC | 99 |
| Epinephrine Other prescribers in Charleston, SC | 51 |
| Montelukast Sodium Other prescribers in Charleston, SC | 50 |
| Dupixent Pen (dupilumab) Other prescribers in Charleston, SC | 37 |
| Spiriva Respimat (tiotropium bromide) Other prescribers in Charleston, SC | 30 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Charleston, SC | 26 |
| Symbicort (budesonide/formoterol fumarate) Other prescribers in Charleston, SC | 22 |
| Fluticasone-Salmeterol (fluticasone propion/salmeterol) Other prescribers in Charleston, SC | 22 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 20 companies reported 206 payments worth $116,517 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $74,964 |
|---|---|
| Genzyme Corporation | $13,035 |
| Optinose US, Inc. | $9,864 |
| Regeneron Healthcare Solutions, Inc. | $9,364 |
| GlaxoSmithKline, LLC. | $6,917 |
| Novartis Pharmaceuticals Corporation | $1,327 |
| Stryker Corporation | $176 |
| Csl Behring | $152 |
| Compensation for services other than consulting (speaking, faculty) | $101,833 |
|---|---|
| Travel and Lodging | $6,568 |
| Food and Beverage | $4,852 |
| Consulting Fee | $3,130 |
| Education | $134 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Genzyme Corporation Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT; DUPIXENT · Immunology | $5,597 |
| AstraZeneca Pharmaceuticals LP Nov 21, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $4,720 |
| GlaxoSmithKline, LLC. Jan 23, 2025 | Compensation for services other than consulting (speaking, faculty) NUCALA · IMMUNOLOGY | $3,900 |
| AstraZeneca Pharmaceuticals LP Jan 27, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
| AstraZeneca Pharmaceuticals LP Mar 3, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
| AstraZeneca Pharmaceuticals LP Nov 3, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
| AstraZeneca Pharmaceuticals LP Jan 14, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
| AstraZeneca Pharmaceuticals LP Aug 28, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
| AstraZeneca Pharmaceuticals LP Apr 11, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
| AstraZeneca Pharmaceuticals LP Apr 1, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
All 102 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Genzyme Corporation Dec 10, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $533 |
| AstraZeneca Pharmaceuticals LP Dec 10, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Hilton Head Island, SC · in-kind Company’s descriptionSpeaker Expenses | $177 |
| AstraZeneca Pharmaceuticals LP Dec 9, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $1,770 |
| AstraZeneca Pharmaceuticals LP Nov 24, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $2,360 |
| AstraZeneca Pharmaceuticals LP Nov 24, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $450 |
| AstraZeneca Pharmaceuticals LP Nov 21, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $4,720 |
| AstraZeneca Pharmaceuticals LP Nov 16, 2025 | Travel and Lodging AIRSUPRA · Respiratory · travel to Rock Hill, SC · in-kind Company’s descriptionSpeaker Expenses | $224 |
| AstraZeneca Pharmaceuticals LP Nov 13, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to SUMMERVILLE, SC · in-kind Company’s descriptionSpeaker Expenses | $21.00 |
| AstraZeneca Pharmaceuticals LP Nov 12, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Daniel Island, SC · in-kind Company’s descriptionSpeaker Expenses | $10.50 |
| AstraZeneca Pharmaceuticals LP Nov 3, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
| GlaxoSmithKline, LLC. Oct 23, 2025 | Travel and Lodging NUCALA · IMMUNOLOGY · travel to Columbia, SC | $168 |
| AstraZeneca Pharmaceuticals LP Oct 22, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Marietta, GA · in-kind Company’s descriptionSpeaker Expenses | $192 |
| AstraZeneca Pharmaceuticals LP Oct 22, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Marietta, GA · in-kind Company’s descriptionSpeaker Expenses | $50.00 |
| AstraZeneca Pharmaceuticals LP Oct 22, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Marietta, GA · in-kind Company’s descriptionSpeaker Expenses | $22.00 |
| AstraZeneca Pharmaceuticals LP Oct 16, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $1,400 |
| GlaxoSmithKline, LLC. Oct 14, 2025 | Compensation for services other than consulting (speaking, faculty) NUCALA · IMMUNOLOGY | $2,600 |
| AstraZeneca Pharmaceuticals LP Oct 8, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Mount Pleasant, SC · in-kind Company’s descriptionSpeaker Expenses | $14.00 |
| AstraZeneca Pharmaceuticals LP Oct 3, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $950 |
| AstraZeneca Pharmaceuticals LP Oct 2, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $1,400 |
| AstraZeneca Pharmaceuticals LP Sep 30, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $950 |
| Novartis Pharmaceuticals Corporation Sep 26, 2025 | Travel and Lodging Rhapsido · Immunology · travel to Chicago, IL · in-kind | $397 |
| Novartis Pharmaceuticals Corporation Sep 26, 2025 | Travel and Lodging Rhapsido · Immunology · travel to Chicago, IL · in-kind | $341 |
| Novartis Pharmaceuticals Corporation Sep 26, 2025 | Travel and Lodging Rhapsido · Immunology · travel to Chicago, IL | $73.00 |
| AstraZeneca Pharmaceuticals LP Sep 23, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $125 |
| AstraZeneca Pharmaceuticals LP Sep 22, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $1,850 |
| AstraZeneca Pharmaceuticals LP Sep 18, 2025 | Travel and Lodging FASENRA · Respiratory · travel to Summerville, SC · in-kind Company’s descriptionSpeaker Expenses | $37.10 |
| AstraZeneca Pharmaceuticals LP Sep 16, 2025 | Travel and Lodging AIRSUPRA · Respiratory · travel to Summerville, SC · in-kind Company’s descriptionSpeaker Expenses | $37.10 |
| Sanofi-aventis U.S. LLC Sep 9, 2025 | Education DUPIXENT · Immunology · in-kind | $99.99 |
| AstraZeneca Pharmaceuticals LP Sep 8, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $3,250 |
| AstraZeneca Pharmaceuticals LP Aug 29, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $1,400 |
| AstraZeneca Pharmaceuticals LP Aug 28, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
| AstraZeneca Pharmaceuticals LP Aug 27, 2025 | Travel and Lodging FASENRA · Respiratory · travel to Augusta, GA · in-kind Company’s descriptionSpeaker Expenses | $192 |
| AstraZeneca Pharmaceuticals LP Aug 27, 2025 | Travel and Lodging FASENRA · Respiratory · travel to Augusta, GA · in-kind Company’s descriptionSpeaker Expenses | $132 |
| AstraZeneca Pharmaceuticals LP Aug 27, 2025 | Travel and Lodging FASENRA · Respiratory · travel to Augusta, GA · in-kind Company’s descriptionSpeaker Expenses | $22.00 |
| AstraZeneca Pharmaceuticals LP Aug 27, 2025 | Travel and Lodging AIRSUPRA · Respiratory · travel to Augusta, GA · in-kind Company’s descriptionSpeaker Expenses | $7.00 |
| AstraZeneca Pharmaceuticals LP Aug 26, 2025 | Travel and Lodging AIRSUPRA · Respiratory · travel to Augusta, GA · in-kind Company’s descriptionSpeaker Expenses | $115 |
| AstraZeneca Pharmaceuticals LP Aug 19, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $450 |
| AstraZeneca Pharmaceuticals LP Aug 15, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $1,400 |
| AstraZeneca Pharmaceuticals LP Aug 12, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to North Charleston, SC · in-kind Company’s descriptionSpeaker Expenses | $25.20 |
| AstraZeneca Pharmaceuticals LP Aug 5, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $250 |
| Amgen Inc. Jul 29, 2025 | Education in-kind | $34.00 |
| AstraZeneca Pharmaceuticals LP Jul 28, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $1,400 |
| AstraZeneca Pharmaceuticals LP Jul 23, 2025 | Travel and Lodging AIRSUPRA · Respiratory · travel to Charleston, SC · in-kind Company’s descriptionSpeaker Expenses | $21.50 |
| Regeneron Healthcare Solutions, Inc. Jul 22, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $1,583 |
| AstraZeneca Pharmaceuticals LP Jun 19, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $1,400 |
| Optinose US, Inc. Jun 18, 2025 | Compensation for services other than consulting (speaking, faculty) Xhance · Otolaryngology (Ear, Nose, Throat) | $3,025 |
| Optinose US, Inc. Jun 18, 2025 | Travel and Lodging Xhance · Otolaryngology (Ear, Nose, Throat) · travel to SURFSIDE BEACH, SC | $137 |
| AstraZeneca Pharmaceuticals LP Jun 17, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $1,850 |
| AstraZeneca Pharmaceuticals LP Jun 12, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Charleston, SC · in-kind Company’s descriptionSpeaker Expenses | $25.90 |
| AstraZeneca Pharmaceuticals LP Jun 10, 2025 | Travel and Lodging AIRSUPRA · Respiratory · travel to North Charleston, SC · in-kind Company’s descriptionSpeaker Expenses | $26.60 |
| AstraZeneca Pharmaceuticals LP Jun 9, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $1,850 |
| Regeneron Healthcare Solutions, Inc. Jun 6, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $950 |
| AstraZeneca Pharmaceuticals LP May 22, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Daniel Island, SC · in-kind Company’s descriptionSpeaker Expenses | $17.50 |
| AstraZeneca Pharmaceuticals LP May 21, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $450 |
| AstraZeneca Pharmaceuticals LP May 7, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $1,400 |
| AstraZeneca Pharmaceuticals LP May 5, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $3,250 |
| AstraZeneca Pharmaceuticals LP Apr 30, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Austell, GA · in-kind Company’s descriptionSpeaker Expenses | $697 |
| AstraZeneca Pharmaceuticals LP Apr 30, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Austell, GA · in-kind Company’s descriptionSpeaker Expenses | $154 |
| AstraZeneca Pharmaceuticals LP Apr 30, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Woodstock, GA · in-kind Company’s descriptionSpeaker Expenses | $30.00 |
| Genzyme Corporation Apr 15, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT; DUPIXENT · Immunology | $2,932 |
| Regeneron Healthcare Solutions, Inc. Apr 15, 2025 | Compensation for services other than consulting (speaking, faculty) | $2,078 |
| Regeneron Healthcare Solutions, Inc. Apr 15, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $1,593 |
| Genzyme Corporation Apr 15, 2025 | Travel and Lodging DUPIXENT; DUPIXENT · Immunology · travel to Charleston, SC | $19.60 |
| AstraZeneca Pharmaceuticals LP Apr 11, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
| Genzyme Corporation Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT; DUPIXENT · Immunology | $5,597 |
| Genzyme Corporation Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $2,932 |
| Genzyme Corporation Apr 9, 2025 | Travel and Lodging DUPIXENT; DUPIXENT · Immunology · travel to Belmont, NC | $305 |
| Genzyme Corporation Apr 9, 2025 | Travel and Lodging DUPIXENT; DUPIXENT · Immunology · travel to Belmont, NC | $216 |
| Optinose US, Inc. Apr 8, 2025 | Compensation for services other than consulting (speaking, faculty) Xhance · Otolaryngology (Ear, Nose, Throat) | $1,500 |
| AstraZeneca Pharmaceuticals LP Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $125 |
| AstraZeneca Pharmaceuticals LP Apr 4, 2025 | Travel and Lodging AIRSUPRA · Respiratory · travel to Sumter, SC · in-kind Company’s descriptionSpeaker Expenses | $105 |
| AstraZeneca Pharmaceuticals LP Apr 2, 2025 | Consulting Fee FASENRA · Respiratory | $465 |
| AstraZeneca Pharmaceuticals LP Apr 1, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
| AstraZeneca Pharmaceuticals LP Apr 1, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $100 |
| AstraZeneca Pharmaceuticals LP Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $1,400 |
| AstraZeneca Pharmaceuticals LP Mar 26, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Atlanta, GA · in-kind Company’s descriptionSpeaker Expenses | $407 |
| AstraZeneca Pharmaceuticals LP Mar 26, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Marietta, GA · in-kind Company’s descriptionSpeaker Expenses | $218 |
| AstraZeneca Pharmaceuticals LP Mar 26, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Marietta, GA · in-kind Company’s descriptionSpeaker Expenses | $29.50 |
| AstraZeneca Pharmaceuticals LP Mar 21, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $1,400 |
| Optinose US, Inc. Mar 12, 2025 | Compensation for services other than consulting (speaking, faculty) Xhance · Otolaryngology (Ear, Nose, Throat) | $3,025 |
| Optinose US, Inc. Mar 12, 2025 | Compensation for services other than consulting (speaking, faculty) Xhance · Otolaryngology (Ear, Nose, Throat) | $1,235 |
| Optinose US, Inc. Mar 12, 2025 | Travel and Lodging Xhance · Otolaryngology (Ear, Nose, Throat) · travel to NORTH AUGUSTA, SC | $338 |
| Optinose US, Inc. Mar 12, 2025 | Travel and Lodging Xhance · Otolaryngology (Ear, Nose, Throat) · travel to AUGUSTA, GA | $262 |
| AstraZeneca Pharmaceuticals LP Mar 3, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
| AstraZeneca Pharmaceuticals LP Feb 26, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Douglasville, GA · in-kind Company’s descriptionSpeaker Expenses | $597 |
| AstraZeneca Pharmaceuticals LP Feb 26, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Douglasville, GA · in-kind Company’s descriptionSpeaker Expenses | $126 |
| AstraZeneca Pharmaceuticals LP Feb 26, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Douglasville, GA · in-kind Company’s descriptionSpeaker Expenses | $116 |
| AstraZeneca Pharmaceuticals LP Feb 26, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Douglasville, GA · in-kind Company’s descriptionSpeaker Expenses | $49.75 |
| Regeneron Healthcare Solutions, Inc. Feb 21, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $1,599 |
| Regeneron Healthcare Solutions, Inc. Feb 21, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $533 |
| Regeneron Healthcare Solutions, Inc. Feb 21, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $533 |
| AstraZeneca Pharmaceuticals LP Feb 18, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $450 |
| AstraZeneca Pharmaceuticals LP Feb 7, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $1,850 |
| Regeneron Healthcare Solutions, Inc. Feb 7, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to AUGUSTA, GA · in-kind | $225 |
| AstraZeneca Pharmaceuticals LP Jan 27, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
| AstraZeneca Pharmaceuticals LP Jan 27, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $1,400 |
| GlaxoSmithKline, LLC. Jan 23, 2025 | Compensation for services other than consulting (speaking, faculty) NUCALA · IMMUNOLOGY | $3,900 |
| AstraZeneca Pharmaceuticals LP Jan 14, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
| AstraZeneca Pharmaceuticals LP Jan 14, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $1,400 |
| AstraZeneca Pharmaceuticals LP Jan 12, 2025 | Travel and Lodging AIRSUPRA · Respiratory · travel to Myrtle Beach, SC · in-kind Company’s descriptionSpeaker Expenses | $145 |
| AstraZeneca Pharmaceuticals LP Jan 8, 2025 | Travel and Lodging AIRSUPRA · Respiratory · travel to Mount Pleasant, SC · in-kind Company’s descriptionSpeaker Expenses | $13.44 |
| GlaxoSmithKline, LLC. Jan 7, 2025 | Travel and Lodging NUCALA · IMMUNOLOGY · travel to Summerville, SC | $32.16 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 6 industry-funded studies in 2025, from 5 companies. The companies reported $377,862 in research payments for these studies, mostly to the institutions running them.
- A US Phase 3b, Multi-center, Randomized, Double-blind, Double-Dummy Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Contro…
Novartis Pharmaceuticals Corporation - Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps
Paratek Pharmaceuticals, Inc. · Recruiting · NCT06850805 - A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy, and Safety Study of Povorcitinib in Participants With Chronic Spontaneous Urticaria
Incyte Corporation - Registry of Asthma Patients Initiating DUPIXENT®
Regeneron Pharmaceuticals, Inc. · Completed · NCT04287621 - A Multicenter Randomized Double Blind Parallel Group Placebo Controlled Phase 3 Efficacy and Safety Study of Tezepelumab in Patients with Severe Chronic Rhinosinusitis with Nasal Polyposis WAYPOINT
AstraZeneca Pharmaceuticals LP - Study Assessing Long-teRm Outcomes of dupiluMAb (DUPIXENT®) Treatment in Adult Patients With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)
Regeneron Pharmaceuticals, Inc. · Active, not recruiting · NCT04959448
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.